168 related articles for article (PubMed ID: 27252463)
1. Novel Method Based on Real-Time Cell Analysis for Drug Susceptibility Testing of Herpes Simplex Virus and Human Cytomegalovirus.
Piret J; Goyette N; Boivin G
J Clin Microbiol; 2016 Aug; 54(8):2120-7. PubMed ID: 27252463
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases.
Zarrouk K; Zhu X; Goyette N; Piret J; Shi R; Boivin G
Antiviral Res; 2021 Apr; 188():105046. PubMed ID: 33588012
[TBL] [Abstract][Full Text] [Related]
4. Anti-herpesvirus activity of carbocyclic oxetanocin G in vitro.
Nishiyama Y; Yamamoto N; Yamada Y; Daikoku T; Ichikawa Y; Takahashi K
J Antibiot (Tokyo); 1989 Dec; 42(12):1854-9. PubMed ID: 2559911
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of ganciclovir elaidic acid ester against herpesviruses.
Andrei G; Snoeck R; Neyts J; Sandvold ML; Myhren F; De Clercq E
Antiviral Res; 2000 Mar; 45(3):157-67. PubMed ID: 10771080
[TBL] [Abstract][Full Text] [Related]
6. Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein.
Talarico CL; Burnette TC; Miller WH; Smith SL; Davis MG; Stanat SC; Ng TI; He Z; Coen DM; Roizman B; Biron KK
Antimicrob Agents Chemother; 1999 Aug; 43(8):1941-6. PubMed ID: 10428917
[TBL] [Abstract][Full Text] [Related]
7. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity.
Hutterer C; Milbradt J; Hamilton S; Zaja M; Leban J; Henry C; Vitt D; Steingruber M; Sonntag E; Zeitträger I; Bahsi H; Stamminger T; Rawlinson W; Strobl S; Marschall M
Antiviral Res; 2017 Jul; 143():113-121. PubMed ID: 28400201
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus-1 entrapped in Candida albicans biofilm displays decreased sensitivity to antivirals and UVA1 laser treatment.
Ascione C; Sala A; Mazaheri-Tehrani E; Paulone S; Palmieri B; Blasi E; Cermelli C
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):72. PubMed ID: 29137671
[TBL] [Abstract][Full Text] [Related]
10. The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replication.
Neyts J; Andrei G; Snoeck R; Jähne G; Winkler I; Helsberg M; Balzarini J; De Clercq E
Antimicrob Agents Chemother; 1994 Dec; 38(12):2710-6. PubMed ID: 7695251
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
[TBL] [Abstract][Full Text] [Related]
12. Cell culture replication of herpes simplex virus and, or human cytomegalovirus is inhibited by 3,7-dialkoxylated, 1-hydroxyacridone derivatives.
Lowden CT; Bastow KF
Antiviral Res; 2003 Aug; 59(3):143-54. PubMed ID: 12927304
[TBL] [Abstract][Full Text] [Related]
13. Novel method based on "en passant" mutagenesis coupled with a gaussia luciferase reporter assay for studying the combined effects of human cytomegalovirus mutations.
Drouot E; Piret J; Boivin G
J Clin Microbiol; 2013 Oct; 51(10):3216-24. PubMed ID: 23863570
[TBL] [Abstract][Full Text] [Related]
14. A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains.
Prix L; Maierl J; Jahn G; Hamprecht K
J Clin Virol; 1998 Jul; 11(1):29-37. PubMed ID: 9784141
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of 9-[[(ethoxyhydroxyphosphinyl)-methoxy]methoxy] guanine against cytomegalovirus and herpes simplex virus.
Kim HT; Kim DK; Kim YW; Kim KH; Sugiyama Y; Kikuchi M
Antiviral Res; 1995 Nov; 28(3):243-51. PubMed ID: 8629816
[TBL] [Abstract][Full Text] [Related]
16. Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir.
Lee GC; Lee DG; Choi SM; Yoo JH; Park SH; Choi JH; Min WS; Cho OH; Lee CH; Shin WS
J Clin Microbiol; 2005 Oct; 43(10):5003-8. PubMed ID: 16207954
[TBL] [Abstract][Full Text] [Related]
17. Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo.
Freitas VR; Fraser-Smith EB; Matthews TR
Antiviral Res; 1989 Nov; 12(4):205-12. PubMed ID: 2559657
[TBL] [Abstract][Full Text] [Related]
18. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay.
Eckle T; Jahn G; Hamprecht K
J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2.
Tardif KD; Jorgensen S; Langer J; Prichard M; Schlaberg R
J Clin Virol; 2014 Nov; 61(3):382-6. PubMed ID: 25204613
[TBL] [Abstract][Full Text] [Related]
20. [Combined activity of meliacin and foscarnet against different strains of herpes simplex virus type 1 using a three-dimensional model].
Barquero AA; Villamil SM
Rev Argent Microbiol; 1997; 29(1):32-7. PubMed ID: 9229723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
